Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer - Damrauer, Jeffrey S.; Beckabir, Wolfgang; Klomp, Jeff; Zhou, Mi; Plimack, Elizabeth R.; Galsky, Matthew D.; Grivas, Petros; Hahn, Noah M.; O’Donnell, Peter H.; Iyer, Gopa; Quinn, David I.; Vincent, Benjamin G.; et al. (Nature communications, 2022)
Keywords: 13/51; 38; 45; 45/23; 45/91; 631/67/1059/2325; 631/67/322; 631/67/589/1336; 692/4025/1334; 692/4028/67/69; Bladder; Bladder cancer; Cancer; Cancer therapies; Carcinoma, Transitional Cell - genetics; Chemotherapy; Computer applications; DNA sequencing; Genomes; Genomic analysis; Genomics; High-Throughput Nucleotide Sequencing; Humanities and Social Sciences; Humans; Immune checkpoint inhibitors; Inflammation; Metastases; Metastasis; multidisciplinary; Mutation; Next-generation sequencing; Patients; Phenotypes; Repositories; Science; Science (multidisciplinary); Stroma; Tumors; Urinary Bladder - pathology; Urinary Bladder Neoplasms - pathology; Urothelial cancer; Urothelial carcinoma